Rene Bernards's Insider Trades & SAST Disclosures

Rene Bernards's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 10,662 Options to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2025.

Share

Note

This is a custom search result for pattern Rene Bernards.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2025	10,662	10,662	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2025	10,000	10,000	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2025	8,045	8,045	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2025	4,166	4,166	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2024	5,304	5,304	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2024	10,000	10,000	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2024	4,149	4,149	-		-	Options to Purchase Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Purchase of securities on an exchange or from another person at price $ 0.61 per share.	12 Dec 2022	10,000	135,000	-	0.6	6,100	Common Stock
Lixte Biotechnology Holdin...	Rene Bernards	Director	Purchase of securities on an exchange or from another person at price $ 0.53 per share.	14 Nov 2022	52,500	125,000	-	0.5	27,825	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades